Eben Tessari
2022
In 2022, Eben Tessari earned a total compensation of $1.9M as Senior Vice President and Chief Operating Officer at Kiniksa Pharmaceuticals, Ltd..
Compensation breakdown
| Non-Equity Incentive Plan | $195,782 |
|---|---|
| Option Awards | $1,022,122 |
| Salary | $443,534 |
| Stock Awards | $251,578 |
| Other | $4,435 |
| Total | $1,917,452 |
Tessari received $1M in option awards, accounting for 53% of the total pay in 2022.
Tessari also received $195.8K in non-equity incentive plan, $443.5K in salary, $251.6K in stock awards and $4.4K in other compensation.
Rankings
In 2022, Eben Tessari's compensation ranked 1,823rd out of 5,736 executives tracked by ExecPay. In other words, Tessari earned more than 68.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,823 out of 5,736 | 68th |
Division Manufacturing | 958 out of 3,125 | 69th |
Major group Chemicals And Allied Products | 392 out of 1,416 | 72nd |
Industry group Drugs | 358 out of 1,317 | 73rd |
Industry Pharmaceutical Preparations | 257 out of 963 | 73rd |
Source: SEC filing on April 27, 2023.
Tessari's colleagues
We found two more compensation records of executives who worked with Eben Tessari at Kiniksa Pharmaceuticals, Ltd. in 2022.